Skip to main content
Original article

Comparative analysis of the effects of dalteparin and reviparin on perioperative blood loss in patients with extracapsular hip fractures treated with intramedullary nailing

Authors
  • Mirza Sivro orcid logo (Canton Hospital Zenica, Zenica, Department of Orthopaedics and Traumatology, Bosnia and Herzegovina)
  • Faruk Lazović (University of Sarajevo, Sarajevo, Orthopaedics and Traumatology Clinic, Clinical Centre, Bosnia and Herzegovina)
  • Ðemil Omerović (Clinical Centre, University of Sarajevo, Sarajevo, Orthopaedics and Traumatology Clinic, Bosnia and Herzegovina)
  • Tarik Kapidžić (Canton Hospital Zenica, Zenica, Department of Orthopaedics and Traumatology, Bosnia and Herzegovina)
  • Adnan Papović (Clinical Centre, University of Sarajevo, Sarajevo, Orthopaedics and Traumatology Clinic, Bosnia and Herzegovina)
  • Mirza Omerčević (Canton Hospital Zenica, Zenica, Department of Orthopaedics and Traumatology, Bosnia and Herzegovina)
  • Harun Selimović (Canton Hospital Zenica, Zenica, Department of Cardiology, Bosnia and Herzegovina)

Abstract

Aim: To determine differences between reviparin and dalteparin treatment in patients with extracapsular hip fractures treated with intramedullary nailing and their effects on perioperative blood loss and early postoperative recovery.

Methods: Retrospective comparative study included 68 patients with extracapsular hip fracture who were divided into dalteparin and reviparin group. Medical records were used to obtain demographic data, laboratory parameters, haemoglobin and haematocrit levels, platelet count, mortality rate and medical complications.

Results: Out of total 68 patients, 31 were in reviparin and 37 in dalteparin group. Mean age of patients was 70.5 (±14.4) and 76.8 (±8.4) years in reviparin and dalteparin group, respectively (p=0.071). Median values of haemoglobin levels on the first postoperative day were lower in dalteparin group compared to reviparin group (p=0.012). On the first postoperative day haematocrit values were also lower in dalteparin than in reviparin group (p=0.015). Both groups showed an increase in platelet count on the first postoperative day, but without significant difference (p=0.084). There was no statistically significant difference in intrahospital mortality between the groups (6.4% vs. 2.7%; p=0.588). One case of pulmonary embolism was detected in the dalteparin group.

Conclusion: Low-molecular-weight heparin is the drug of choice in patients with hip fractures for thromboprophylaxis. Due to non-antithrombin-mediated actions, reviparin and dalteparin could have different effects on perioperative blood loss. Both dalteparin and reviparin are safe and effective agents for thromboprophylaxis in patients with proximal femur fractures.

Keywords: anticoagulants, femur, haemorrhage

How to Cite:

Sivro, M., Lazović, F., Omerović, Ð., Kapidžić, T., Papović, A., Omerčević, M. & Selimović, H., (2022) “Comparative analysis of the effects of dalteparin and reviparin on perioperative blood loss in patients with extracapsular hip fractures treated with intramedullary nailing”, Medicinski glasnik 20(1), 1-6. doi: https://doi.org/10.17392/1526-22

Downloads:
Download PDF
View PDF

0 Views

0 Downloads

Published on
2022-08-27

Peer Reviewed

License

CC-BY-NC-ND 4.0